Skip to main content
. 2021 Feb 22;15(2):e0009103. doi: 10.1371/journal.pntd.0009103

Fig 4. The favipiravir concentration of the patients with SFTS who were administered favipiravir orally.

Fig 4

The data were analyzed from the favipiravir concentrations of seven patients. Black and grey dotted lines indicate the mean concentration of favipiravir and predicted concentration of individual patients, respectively. Round circles indicate the concentration of each individual at the designated time points.